- This event has passed.
4th Annual CEO Summit
September 23, 2016
A funny thing happened on the way to the Market…
With insights from McKinsey & Company
CLICK HERE for Full Program Agenda
Whether you plan to take your product all the way to market or not, BioNJ’s 4th Annual CEO Summit examines the critical factors that need to be considered along your journey. Whether large or small, public or private, pre-revenue or not…this robust agenda addresses the challenges that the C Suite faces day in day out — from fundraising to financing…politics to pricing.
Taking place Friday, September 23, 2016, at the Bridgewater Marriott, this meeting will bring together more than 200 life sciences C-suite leaders and those who support them.
Entitled “A Funny Thing Happened on the Way to the Market…With Insights from McKinsey & Company,” the CEO Summit will showcase an outstanding roster of key stakeholders at the forefront of this vital conversation.
7:00 a.m. – 8:15 a.m.
Registration & Networking Breakfast Buffet
|8:15 a.m. – 8:30 a.m.||
Welcome & Opening Remarks by Debbie Hart, President & CEO, BioNJ
|8:30 a.m. – 9:15 a.m.||
On the Way to Market: What Should Biopharma Companies Pre-Revenue to Large-Cap be Thinking About?
This session will provide an aerial view of the access landscape, highlighting real trends vs. noise — and what you should do about it.
Speaker: BJ Tevelow, M.D., Director, McKinsey & Company
|9:15 a.m. – 10:15 a.m.||
How Not to be Left on the Side of the Road – An Industry Perspective
A panel of experts will share industry perspectives on how to prepare for reimbursement success in an uncertain environment.
Panelists: Mark Alles, CEO Celgene; Susan Shiff, Ph.D., Sr. Vice President & Head of the Center for Observational & Real-World Evidence, Merck & Co.; Robert Ward, President & CEO, Radius Health and Dieter Weinand, Member of the Board of Management of Bayer AG, President Pharmaceuticals & Chairman of the Board of Management of Bayer Pharma AG
Moderated by: Brett Davis, Partner, Deloitte Consulting & General Manager, ConvergeHEALTH
|10:15 a.m. – 10:45 a.m.||
How to Evolve Your Commercialization Model – What are the Right Commercial Strategies?
Learn tactics on how to evolve your commercial model, including options to consider, when to approach key stakeholders and how and when to engage patients.
Fireside Chat With: Karin Hehenberger M.D., Ph.D., Founder Chairman & CEO, LYFEBULB and Jesper Høiland, Executive Vice President, U.S., Novo Nordisk
Moderated by: Jeffrey Stoll, Ph.D., Vice President, EY
|10:45 a.m. – 11:00 a.m.||
|11:00 a.m. – 11:45 a.m.||
Pricing is in the Headlines: The Market Perspective – What Does the New World of Pricing Look Like?
This panel discussion will focus on what the new world of pricing looks like, including assessing value, policy direction and evolving stakeholder positions.
Panelists: Murray Aitken, SVP & Executive Director, IMS Institute for Healthcare Informatics; Meg Alexander, Head, Issues Management Practice, inVentiv Health; Robert Goldberg, M.D., Vice President & Co-Founder, Center for Medicine in the Public Interest; Linda Pissott Reig, Shareholder, Buchanan Ingersoll and Rooney PC and Harry Travis, President & CEO, eTech, Inc. and Former Vice President, Aetna Specialty and Home Delivery Pharmacy;
|11:45 a.m. – 12:15 p.m.||
Tales from the Road: Thoughts on Raising Capital
Hear from CEOs who have gone through the process of fund raising, including challenges and opportunities, creative approaches, timing, tips to consider and pitfalls to avoid.
Speakers: Daniel O’Connor, President, CEO & Director, Advaxis; Geert Cauwenbergh Ph.D., Med.Sc., President & CEO, RXi Pharmaceuticals
Moderated by: David C. Schwartz, Partner, DLA Piper
|12:15 p.m. – 12:45 p.m.||
Staying Alive: Financial Sustainability in this Environment
Enjoy a candid discussion with biopharma investors on how they view investment opportunities in today’s market.
Fireside Chat With: Sam Hall, Ph.D., Principal, Apple Tree Partners and Carlo Rizzuto, Ph.D., Partner, Versant Ventures
Interviewed by: Fedora Baloiu, Head of the Biopharmaceutical Practice, Houlihan Lokey
|12:45 p.m. – 1:00 p.m.||
|1:00 p.m. – 2:15 p.m.||
Luncheon & Keynote Fireside Chat: Discussing Medical Innovation, the Value of Biopharmaceuticals and the 2016 Presidential Election’s Impact on this Important Conversation
BIO’s President and CEO Jim Greenwood will share his view of the Presidential Race and its impact on medical innovation.
Jim Greenwood, President & CEO, Biotechnology Innovation Organization (BIO)
Interviewed by: Debbie Hart, President & CEO, BioNJ
|2:15 p.m. – 3:00 p.m.||
You’ve Done It – Market Perspectives and Lessons Learned
A frank discussion with Biogen Chairman and respected industry leader, Dr. Stelios Papadopoulos, about holistic lessons learned on “getting to market”.
Fireside Chat With: Stelios Papadopoulos, Ph.D., Chairman, Biogen
Moderated by: Lindsay McKenna, Ph.D., Associate Principal, McKinsey & Company
|3:00 p.m. – 4:00 p.m.||
Closing Remarks & Dessert Networking Reception